84 phenotypes from 3 alleles in 4 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Chd2em1Wei/Chd2em1Wei involves: BALB/c * C57BL/6	decreased body weight	J:281371
	prenatal lethality, incomplete penetrance	J:281371
Chd2Gt(RRBO46)Byg/Chd2+ involves: 129P2/OlaHsd * C57BL/6	abnormal blood vessel morphology	J:146176
	abnormal kidney morphology	J:146176
	abnormal liver morphology	J:146743
	abnormal lung morphology	J:146743
	abnormal respiratory system physiology	J:146743
	abnormal spleen morphology	J:146743
	arteritis	J:146176
	bile duct hyperplasia	J:146743
	cardiac fibrosis	J:146743
	cardiomyopathy	J:146743
	cortical renal glomerulopathies	J:146743
	decreased birth body size	J:146176
	decreased body size	J:146176
	decreased body weight	J:146743
	decreased lymphocyte cell number	J:146176
	decreased survivor rate	J:146176, J:146743
	decreased white adipose tissue amount	J:146743
	disheveled coat	J:146743
	enlarged heart	J:146743
	enlarged lymph nodes	J:146743
	enlarged spleen	J:146743
	extramedullary hematopoiesis	J:146176, J:146743
	heart inflammation	J:146176
	hemorrhage	J:146176
	hepatic necrosis	J:146743
	increased CD4-positive, alpha-beta T cell number	J:146176
	increased lymphoma incidence	J:146176
	increased spleen red pulp amount	J:146743
	increased T cell derived lymphoma incidence	J:146176
	interstitial pneumonia	J:146743
	kyphosis	J:146176, J:146743
	lethargy	J:146743
	lipidosis	J:146743
	liver inflammation	J:146743
	lordosis	J:146176
	lymphoid hyperplasia	J:146176
	myocardial fiber degeneration	J:146743
	myocarditis	J:146743
	pale kidney	J:146743
	postnatal growth retardation	J:146743
	postnatal lethality, incomplete penetrance	J:146176, J:146743
	premature death	J:146176, J:146743
	pulmonary alveolar edema	J:146743
	pulmonary alveolar hemorrhage	J:146743
	tachypnea	J:146743
	weight loss	J:146176
Chd2Gt(RRBO46)Byg/Chd2+ involves: 129P2/OlaHsd * C57BL/6J	abnormal blood vessel morphology	J:137079
	absent subcutaneous adipose tissue	J:137079
	cortical renal glomerulopathies	J:137079
	decreased body size	J:137079
	decreased subcutaneous adipose tissue amount	J:137079
	endometrium hyperplasia	J:137079
	increased heart atrium size	J:137079
	lordokyphosis	J:137079
	postnatal growth retardation	J:137079
	preweaning lethality, incomplete penetrance	J:137079
	uterus cyst	J:137079
Chd2Gt(RRBO46)Byg/Chd2Gt(RRBO46)Byg involves: 129P2/OlaHsd * C57BL/6	abnormal blood cell morphology/development	J:146176
	abnormal blood vessel morphology	J:146176
	abnormal cell cycle	J:146176
	abnormal DNA repair	J:146176
	abnormal erythropoiesis	J:146176
	decreased erythroid progenitor cell number	J:146176
	decreased fetal size	J:146743
	fetal growth retardation	J:146743
	hemorrhage	J:146176
	increased cellular sensitivity to methylmethanesulfonate	J:146176
	increased cellular sensitivity to ultraviolet irradiation	J:146176
	increased cellular sensitivity to X-ray irradiation	J:146176
	increased megakaryocyte cell number	J:146176
	lethargy	J:146176
	postnatal lethality	J:146176
	postnatal lethality, complete penetrance	J:146743
Chd2Gt(RRBO46)Byg/Chd2Gt(RRBO46)Byg involves: 129P2/OlaHsd * C57BL/6J	abnormal eye morphology	J:137079
	anophthalmia	J:137079
	decreased body size	J:137079
	increased heart atrium size	J:137079
	lethality throughout fetal growth and development, incomplete penetrance	J:137079
	pallor	J:137079
	postnatal lethality, complete penetrance	J:137079
Chd2tm1b(EUCOMM)Hmgu/Chd2tm1b(EUCOMM)Hmgu C57BL/6N-Chd2tm1b(EUCOMM)Hmgu/Tcp	abnormal bone structure	J:211773
	abnormal sinus arrhythmia	J:211773
	decreased body length	J:211773
	decreased bone mineral content	J:211773
	decreased bone mineral density	J:211773
	decreased erythrocyte cell number	J:211773
	decreased hemoglobin content	J:211773
	decreased mean platelet volume	J:211773
	decreased prepulse inhibition	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased grip strength	J:211773
	short tibia	J:211773